World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
31418
World Ranking
16447
National Ranking
854

Overview

Dan Ziegler is affiliated with Heinrich Heine University Düsseldorf in Germany and focuses primarily on medicine, with a concentration in physiology, neurology, pharmacology, endocrinology, diabetes, metabolism, and molecular biology. Their research contributions revolve around key topics such as pain mechanisms and treatments, botulinum toxin and related neurological disorders, pharmacology and obesity treatment, Parkinson's disease mechanisms and treatments, neurological disorders and treatments, heart rate variability and autonomic control, and myofascial pain diagnosis and treatment.

The scientist has authored numerous papers with recent notable publications including:

  • Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations (2021), Diabetes Research and Clinical Practice
  • Current concepts in the management of diabetic polyneuropathy (2020), Journal of Diabetes Investigation

Other influential papers relevant to their domain but authored by others include "Diagnosis and Treatment of Painful Diabetic Peripheral Neuropathy" (2022) published in ADA Clinical Compendia and "Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy" (2022) appearing in Diabetologia.

Frequent collaborations have been established with researchers such as Michael Roden, Gidon J. Bönhof, Christian Herder, Wolfgang Rathmann, and Julia Szendroedi, reflecting a network of co-authors who have jointly contributed to the field over numerous publications.

Ziegler has regularly published in several key venues recognized within the domain of diabetes and metabolic research. These venues include:

  • Diabetologie und Stoffwechsel
  • Diabetologia
  • Diabetes Research and Clinical Practice
  • Die Diabetologie
  • Der Diabetologe

Their research largely addresses clinical and physiological aspects of diabetic neuropathies and related neurological complications, signifying an intersection between clinical practice and experimental investigations.

Best Publications

  • Diabetic neuropathies: a statement by the American Diabetes Association.

    Andrew J.M. Boulton;Andrew J.M. Boulton;Arthur I. Vinik;Joseph C. Arezzo;Vera Bril

  • Diabetic Neuropathy: A Position Statement by the American Diabetes Association

    Rodica Pop-Busui;Andrew J.M. Boulton;Eva L. Feldman;Vera Bril

  • Diabetic Cardiovascular Autonomic Neuropathy

    Aaron I. Vinik;Dan Ziegler

  • Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management

    Vincenza Spallone;Dan Ziegler;Roy Freeman;Luciano Bernardi

  • Treatment of symptomatic diabetic polyneuropathy with the antioxidant α‐lipoic acid: a meta‐analysis

    D. Ziegler;H. Nowak;P. Kempler;P. Vargha

  • Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy The SYDNEY 2 trial

    Dan Ziegler;Alexander Ametov;Alexey Barinov;Peter J. Dyck

  • Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus.

    Miroslav Misha Backonja;Nadine Attal;Ralf Baron;Didier Bouhassira

  • Prevalence of Polyneuropathy in Pre-Diabetes and Diabetes Is Associated With Abdominal Obesity and Macroangiopathy The MONICA/KORA Augsburg Surveys S2 and S3

    Dan Ziegler;Wolfgang Rathmann;Thorsten Dickhaus;Christa Meisinger

  • Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.

    D Ziegler;M Hanefeld;K J Ruhnau;H Hasche

  • Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study

    Giuseppe Lauria;Mayienne Bakkers;Christoph Schmitz;Raffaella Lombardi

  • Methylglyoxal modification of Na v 1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy

    Angelika Bierhaus;Thomas Fleming;Stoyan Stoyanov;Andreas Leffler;Andreas Leffler

  • Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 trial

    Dan Ziegler;Phillip A. Low;William J. Litchy;Andrew J.M. Boulton

  • Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment.

    Dan Ziegler

  • Standardized tests of heart rate variability: normal ranges obtained from 309 healthy humans, and effects of age, gender, and heart rate.

    Marcus W. Agelink;Rolf Malessa;Bruno Baumann;Thomas Majewski

  • The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.

    Alexander S. Ametov;Alexei Barinov;Peter J. Dyck;Robert Hermann

  • α-Lipoic acid in the treatment of diabetic polyneuropathy in Germany : Current evidence from clinical trials

    D. Ziegler;M. Reljanovic;H. Mehnert;F. A. Gries

  • Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study.

    Oana P Zaharia;Klaus Strassburger;Alexander Strom;Gidon J Bönhof

  • Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses.

    Dan Ziegler;G. Laux;K. Dannehl;M. Spüler

  • Mortality in diabetic patients with cardiovascular autonomic neuropathy.

    W. Rathmann;D. Ziegler;M. Jahnke;B. Haastert

  • The Epidemiology of Diabetic Neuropathy

    D Ziegler;F A Gries;M Spüler;F Lessmann

Frequent Co-Authors

Roy Freeman
Roy Freeman Beth Israel Deaconess Medical Center
Phillip A. Low
Phillip A. Low Mayo Clinic
Peter J. Dyck
Peter J. Dyck Mayo Clinic
Andrew J.M. Boulton
Andrew J.M. Boulton University of Manchester
Karl-Josef Langen
Karl-Josef Langen Forschungszentrum Jülich
David Yarnitsky
David Yarnitsky Technion – Israel Institute of Technology
Roman Rolke
Roman Rolke RWTH Aachen University
Smriti Iyengar
Smriti Iyengar Eli Lilly (United States)
Anne Louise Oaklander
Anne Louise Oaklander Harvard University
Eva L. Feldman
Eva L. Feldman University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA, there are several related online degree options and career paths to explore. In addition to traditional medical school, pursuing a career in healthcare administration is increasingly popular. Affordable options like cheap mha programs allow students to develop leadership skills and prepare for healthcare management roles, all with flexible online study.

For those interested in advanced nursing opportunities, there are cheapest dnp online programs available, helping registered nurses earn their Doctor of Nursing Practice at a lower cost without interrupting their careers. Pharmacists can also advance with online pharmacist programs that offer affordable doctorate-level training.

If managing patient data or health systems interests you, you might explore rhia certification programs online. These degrees prepare students for certification and leadership jobs in health information management. Exploring these online options allows aspiring professionals to balance education, affordability, and flexible career advancement.

Best Scientists Citing Dan Ziegler

Trending Scientists